Project Grant R35GM165401
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded University of Wisconsin–Madison a $272,125 Project Grant (CFDA 93.855: Allergy and Infectious Diseases Research) effective July 7, 2026, with completion targeted for June 30, 2028. The award funds research investigating the evolutionary origins and consequences of starship-mediated variation in fungi, with a focus on understanding how giant transposons called starships generate...
- Grant Award Summary The National Science Foundation's Division of Environmental Biology awarded University of Wisconsin - Madison a $1.22 million Project Grant (CFDA 47.074, Biological Sciences program) effective September 1, 2026, through August 31, 2030, to develop a model system for studying horizontal gene transfer (HGT) in fungi. The project capitalizes on the principal investigator's discovery that HGT within fungal eukaryotes is mediated by giant transposons called starships, which can...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded University of Wisconsin–Madison a Project Grant of $414,305.00 (Award Date: March 1, 2026; Completion Date: February 28, 2031) under the Biomedical Research and Research Training program (CFDA 93.859) to develop and implement advanced statistical genetics tools for drug target discovery and treatment optimization. Over the five-year funding period, the project will address critical...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded University of Wisconsin-Milwaukee $572,553 under the Biomedical Research and Research Training program (CFDA 93.859) for a three-year project (September 1, 2025 through August 31, 2028) investigating pleiotropic consequences of mucoid phage resistance in Escherichia coli populations. The research will deliver fundamental scientific knowledge on how bacterial resistance to bacteriophages develops...
- Federal Project Grant Award Summary The Medical College of Wisconsin, Inc. received a $390,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective April 1, 2026 through March 31, 2031. This five-year award supports investigator-initiated research investigating the metabolic regulation of immunity in Caenorhabditis elegans, a model organism used to elucidate fundamental biological...
- Federal Grant Award Summary The University of Wisconsin-Milwaukee is receiving $563,880 in federal funding under a Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) through the Biomedical Research and Research Training program (CFDA 93.859). The award, effective September 1, 2025, through August 31, 2028, supports fundamental research into the regulators of the unfolded protein response (UPR) signaling pathway. The research will investigate how the three major...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded the University of Hawai'i at Mānoa a $395,131 Project Grant (CFDA 93.859: Biomedical Research and Research Training) effective September 1, 2025, through June 30, 2028, to investigate bacterial dispersal mechanisms and molecular transport along fungal hyphae. The research addresses how bacteria (Lysinibacillus and Klebsiella species) utilize fungal hyphae (Fusarium) as dispersal pathways in...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded the University of Wisconsin-Madison a $413,001 R35 Maximizing Investigators' Research Award (MIRA) under the Biomedical Research and Research Training program (CFDA 93.859) to develop computational systems addressing critical challenges in single-cell and spatial transcriptomics experiments. The project, effective April 1, 2026, through February 28, 2031, will deliver powerful and efficient...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) awarded $116,005 to the University of Wisconsin-Madison on May 1, 2026, for a two-year project examining molecular mechanisms of neutrophil reverse migration in wound healing. The research deliverables include identification and characterization of distinct neutrophil subpopulations involved in reverse migration, tracking of their...
- Federal Project Grant Award Summary The University of Wisconsin–Madison received a $124,929 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded July 1, 2026, with completion targeted for June 30, 2028. This award funds investigator-initiated basic biomedical research examining how epithelial tissue architecture regulates leukocyte migration strategies in vivo. The project employs...
The National Institute of General Medical Sciences (NIGMS) awarded the University of Wisconsin–Madison a $415,360 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) effective August 1, 2026, with completion targeted for March 31, 2031. This award funds fundamental research to understand the roles of giant starship transposons in horizontal gene transfer and fungal evolution. The research will characterize previously undiscovered giant transposons (termed "starships") that carry dozens of genes encoding fungal traits such as secondary metabolite production and biofilm formation, and will investigate their mechanisms in facilitating adaptive trait dissemination across fungal species. The deliverables include experimental tools, molecular characterization protocols, and foundational knowledge addressing gaps in current analytical methods that fail to account for starship-mediated horizontal gene transfer in fungi. This basic research initiative directly supports NIGMS's mission to advance understanding of biological processes underlying disease mechanisms and health outcomes. The work addresses urgent knowledge gaps in fungal evolution with long-term applicability to disease mitigation and health management strategies. By elucidating starship transfer mechanisms and their contributions to fungal pathogenesis and mutualism, the research will resolve currently unexplained biological variation in human-associated fungi and provide scientific foundations for innovative approaches to fungal disease control.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $415.4k | 7/9/26 |